MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-14-2023
Biocept ROE Ratio 2011-2025 | BIOC
Annual ROE Ratio Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -362.16 | -7.53 | -75.16 | -224.43 | -807.61 | -1667.68 | -2793.44 | -459.0 | 7193.23 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7193.23 | -2793.44 | 88.47 |
Quarterly ROE Ratio Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1586.6 | -370.84 | -62.43 | -64.03 | -45.48 | -15.4 | 1.88 | -73.25 | -146.78 | -215.68 | -225.39 | -276.4 | -425.36 | -574.33 | -723.29 | -869.96 | -1454.4 | -2038.85 | -2623.3 | -2862.85 | -2503.47 | -2134.2 | -2992.28 | -3190.73 | -5535.11 | -7889.38 | -9016.3 | -8505.68 | -6169.79 | -3833.9 | -1498.01 | 386.82 | 8053.1 | 15719.39 | 23385.67 | 21645.73 | 14460.07 | 7267.29 | 74.13 | 54.28 | 31.32 | 15.46 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23385.67 | -9016.3 | 551.71 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 16.36 | -4.05 % | $ 176 M |  China |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 17.05 | -2.15 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M |  USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.63 | -2.11 % | $ 2.07 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
IQVIA Holdings
IQV
|
22.63 | $ 221.54 | -1.96 % | $ 40.2 B | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 38.85 | 2.32 % | $ 1.08 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Danaher Corporation
DHR
|
7.87 | $ 227.08 | -2.28 % | $ 166 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 11.92 | -6.58 % | $ 338 M | Israel |
 |
DexCom
DXCM
|
26.18 | $ 66.91 | -2.94 % | $ 25.8 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 20.44 | 3.23 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 105.26 | 4.46 % | $ 4.15 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
-62.78 | $ 3.59 | -25.21 % | $ 115 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.58 | 0.21 % | $ 18.8 B | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 0.34 | -2.96 % | $ 9.98 M | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 27.13 | 0.26 % | $ 820 M | USA |
 |
Guardant Health
GH
|
312.48 | $ 102.09 | 0.7 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 26.6 | -1.52 % | $ 20 B |  Niderland |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 134.29 | -1.58 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 192.57 | -0.96 % | $ 9.89 B | USA |
 |
Quidel Corporation
QDEL
|
60.8 | $ 28.79 | -2.93 % | $ 1.21 B | USA |
 |
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 182.21 | 0.35 % | $ 20.2 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 7.94 | -1.0 % | $ 1.03 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 263.51 | -0.46 % | $ 22.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 186.28 | -1.92 % | $ 15.4 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 701.07 | -0.91 % | $ 57.8 B | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.11 | 4.76 % | $ 4.57 B | USA |
 |
Agilent Technologies
A
|
22.45 | $ 139.44 | -2.4 % | $ 42.4 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.55 | -1.07 % | $ 5.86 M | USA |
 |
Bioventus
BVS
|
-90.0 | $ 7.59 | 2.29 % | $ 475 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 395.23 | -1.85 % | $ 29.6 B | Schweiz |
 |
Myriad Genetics
MYGN
|
-18.16 | $ 7.26 | -0.62 % | $ 658 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 5.47 | -7.6 % | $ 2.94 M | USA |